Financial reports
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
ARS
2022 FY
Annual report to shareholders
29 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
Current reports
8-K
Other Events
23 Apr 24
8-K
Material Modifications to Rights of Security Holders
19 Apr 24
8-K
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
17 Apr 24
8-K
Submission of Matters to a Vote of Security Holders
10 Apr 24
8-K
Entry into a Material Definitive Agreement
8 Apr 24
8-K
Departure of Directors or Certain Officers
16 Feb 24
8-K
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
31 Jan 24
8-K
Entry into a Material Definitive Agreement
25 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Jan 24
8-K
Entry into a Material Definitive Agreement
17 Jan 24
Registration and prospectus
S-3/A
Shelf registration (amended)
17 Apr 24
S-3
Shelf registration
14 Feb 24
424B5
Prospectus supplement for primary offering
16 Jan 24
424B5
Prospectus supplement for primary offering
9 Nov 23
S-8
Registration of securities for employees
30 Aug 23
S-8
Registration of securities for employees
19 May 23
S-3
Shelf registration
19 May 23
424B4
Prospectus supplement with pricing info
20 Apr 23
S-1MEF
Registration of additional securities for an S-1
19 Apr 23
S-1/A
IPO registration (amended)
19 Apr 23
Proxies
DEF 14A
Definitive proxy
12 Mar 24
PRE 14A
Preliminary proxy
12 Feb 24
DEFA14A
Additional proxy soliciting materials
29 Jun 23
DEFA14A
Additional proxy soliciting materials
29 Jun 23
DEF 14A
Definitive proxy
29 Jun 23
DEF 14A
Definitive proxy
10 Jan 23
PRER14A
Preliminary revised proxy
6 Jan 23
PRER14A
Preliminary revised proxy
23 Dec 22
PRER14A
Preliminary revised proxy
12 Dec 22
PRE 14A
Preliminary proxy
22 Nov 22
Other
EFFECT
Notice of effectiveness
22 Apr 24
EFFECT
Notice of effectiveness
31 May 23
CORRESP
Correspondence with SEC
25 May 23
UPLOAD
Letter from SEC
24 May 23
EFFECT
Notice of effectiveness
20 Apr 23
CORRESP
Correspondence with SEC
17 Apr 23
CORRESP
Correspondence with SEC
17 Apr 23
UPLOAD
Letter from SEC
21 Feb 23
UPLOAD
Letter from SEC
12 Jan 23
CORRESP
Correspondence with SEC
6 Jan 23
Ownership
SC 13G/A
Lincoln Park Capital Fund, LLC
14 Feb 24
SC 13G/A
Lind Global Fund II LP
13 Feb 24
SC 13G
Flynn James E
1 Feb 24
SC 13G
Duvvuri Krishna
13 Nov 23
4
Craig Fraser
28 Sep 23
4
Craig Fraser
27 Sep 23
3
Jamie McAndrew
5 Sep 23
4
Daniel E. Geffken
29 Aug 23
4
Leslie J. Williams
25 Aug 23
4
Mark Strobeck
25 Aug 23